SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-200094
Filing Date
2019-07-23
Accepted
2019-07-23 16:57:34
Documents
5
Effectiveness Date
2019-07-23

Document Format Files

Seq Description Document Type Size
1 S-8 d713921ds8.htm S-8 44892
2 EX-5.1 d713921dex51.htm EX-5.1 5912
3 EX-23.1 d713921dex231.htm EX-23.1 1449
4 EX-99.1 d713921dex991.htm EX-99.1 421470
5 GRAPHIC g713921g0722202210995.jpg GRAPHIC 2534
  Complete submission text file 0001193125-19-200094.txt   478485
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-232774 | Film No.: 19968286
SIC: 2834 Pharmaceutical Preparations